![](https://investorshub.advfn.com/uicon/9427.png?cb=1492883729)
Monday, April 11, 2022 9:09:48 AM
Recent TRIB News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/12/2024 09:03:40 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/12/2024 08:53:34 PM
- Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 07/12/2024 08:07:02 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/11/2024 10:55:50 AM
- Trinity Biotech Announces Appointment of A New CFO • GlobeNewswire Inc. • 07/09/2024 08:05:00 PM
- Trinity Biotech to Begin European Pre-Pivotal Trial to Optimize its CGM Sensor • GlobeNewswire Inc. • 06/24/2024 11:00:00 AM
- Trinity Biotech Attending 84th Scientific Sessions of the American Diabetes Association • GlobeNewswire Inc. • 06/10/2024 01:10:36 PM
- Trinity Biotech Launches its Continuous Glucose Monitoring Microsite to Showcase its Innovative & Differentiated Technology • GlobeNewswire Inc. • 06/03/2024 08:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/28/2024 11:55:23 AM
- Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance • GlobeNewswire Inc. • 05/23/2024 12:00:32 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/16/2024 05:15:37 PM
- Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI • GlobeNewswire Inc. • 05/16/2024 01:18:57 PM
- Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance for 2024 TrinScreen HIV Sales • GlobeNewswire Inc. • 05/13/2024 03:42:27 PM
- Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development • GlobeNewswire Inc. • 05/08/2024 02:36:58 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/08/2024 04:15:26 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/07/2024 08:25:53 PM
- Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates • GlobeNewswire Inc. • 04/04/2024 11:30:02 AM
- Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results • GlobeNewswire Inc. • 03/28/2024 10:39:07 PM
- Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule • GlobeNewswire Inc. • 03/08/2024 03:03:48 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/15/2024 07:11:36 PM
- Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change • GlobeNewswire Inc. • 02/15/2024 05:34:50 PM
- Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change • GlobeNewswire Inc. • 02/13/2024 02:00:12 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 02/10/2024 12:51:28 AM
- Trinity Biotech to Present at Emerging Growth Conference • GlobeNewswire Inc. • 02/08/2024 01:30:00 PM
- Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code • GlobeNewswire Inc. • 02/07/2024 01:30:00 PM
FEATURED ELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES • Jul 30, 2024 8:00 AM
Avant Technologies Opens Equity Line with GHS Investments as Company Explores Expansion into Additional Technologies • AVAI • Jul 30, 2024 8:00 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • BLOZF • Jul 29, 2024 9:07 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM